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Background: To evaluate the safety, etiology and outcomes of patients undergoing bilateral
thoracentesis.
Methods: This is a prospective cohort study of 100 consecutive patients who underwent bilateral
thoracenteses in an academic medical center from July 2009 through November 2010. Pleural
fluid characteristics and etiologies of the effusions were assessed. Mean differences in levels
of fluid characteristics between right and left lungs were tested. Associations between fluid
characteristics and occurrence of bilateral malignant effusions were evaluated. The rate of
pneumothorax and other complications subsequent to bilateral thoracentesis was determined.
Results: Exudates were more common than transudates, and most effusions had multiple etiol-
ogies, with 83% having two or more etiologies. Bilateral malignant effusions occurred in 19
patients, were the most common single etiology of exudative effusions, and were associated
with higher levels of protein and LDH in the pleural fluid. Among 200 thoracenteses performed
with a bilateral procedure, seven resulted in pneumothoraces, three of which required chest
tube drainage and four were ex vacuo.
Conclusions: More often than not, there are multiple etiologies that contribute to pleural fluid
formation, and of the combinations of etiologies observed congestive heart failure was the most
frequent contributor. Exudative effusions aremore common than transudateswhenbilateral effu-
sions are present. Malignancy is a commonetiology of exudative effusions. This study suggests that
theoverall complication rate followingbilateral thoracentesis is lowand the rate ofpneumothorax
subsequent to bilateral thoracentesis is comparable to unilateral thoracentesis.
ª 2012 Elsevier Ltd. All rights reserved.ity, Section of Pulmonary and Critical Care Medicine, 15 York Street, LCI 100-D, New Haven, CT 06520-
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further drainage occurred. All patients who underwentPleural effusions result from the accumulation of fluid in
the pleural space surrounding the lungs. More than 1.3
million cases occur each year in the United States. The
cause of bilateral pleural effusions is generally thought to
be due to congestive heart failure (CHF), renal or liver
failure, although the only two studies that have objectively
evaluated this assumption draw from markedly different
populations. In a study conducted over 50 years ago, in
cases where patients exhibited normal heart size, only 3.8%
of effusions were attributed to congestive heart failure.1 In
a separate retrospective study, most cases of bilateral
effusions were due to recent coronary artery bypass
grafting (CABG) or heart failure.2 That study also showed
that, on average, characteristics of the fluid were similar
between the left and right sides, including levels of
protein, LDH, glucose, and cell counts. Those authors
concluded that bilateral fluid analysis need not be per-
formed on both sides unless there is a specific clinical
indication.2 There is limited data regarding pleural fluid
etiologies or safety of removing fluid from both hemi-
thoraces at the same time in patients with bilateral pleural
effusions.
The most widely practiced intervention is unilateral
thoracentesis, i.e., the removal of fluid from one hemi-
thorax with a needle or catheter. Pneumothorax is arguably
the most feared complication of thoracentesis and occurs in
approximately 6.0% of cases, of which 34% require chest
tube placement.1 Iatrogenic risk of pneumothorax subse-
quent to thoracentesis decreases with the use of ultra-
sound.3 Whereas unilateral thoracentesis is generally
considered to be safe, complications can substantially
increase morbidity and cost.
Patients with bilateral pleural effusions may benefit
therapeutically from the removal of fluid from both hemi-
thoraces. Conventional wisdom dictates that thoracentesis
should be performed on one side at a time when bilateral
effusions are present, likely from fear of causing bilateral
pneumothoraces or other complications. No study has
examined the safety of performing concurrent bilateral
thoracentesis.
In this observational study we characterized the nature,
characteristics, and etiologies of the bilateral effusions. We
examined factors associated with the occurrence of bilat-
eral malignant effusions. We also report on rate of
complications subsequent to concurrent bilateral thor-
acentesis in both spontaneously breathing and mechan-
ically ventilated patients.
Materials and methods
This was a prospective cohort study conducted at Yale-New
Haven Hospital, a tertiary care medical center. Approval for
this study was obtained by the Institutional Review Board.
The Thoracic Interventional Program (TIP) is routinely con-
sulted to perform diagnostic and therapeutic thoracenteses
for both inpatients and outpatients with pleural effusions.
Inpatients were typically on medical floors or in the medical
intensive care unit (MICU) rather than surgical floors. When
bilateral effusions were present, both hemithoraces weresampled at the same time and fluid was removed until no
bilateral thoracentesis between July of 2009 and November
2010 were included after obtaining informed consent.
Ultrasound (SonoSite S-ICU, Bothell, WA) was used to iden-
tify both effusions and to distinguish the fluid from the
surrounding structures, including the lungs, diaphragm and
subdiaphragmatic structures. Marks were placed to identify
the locations of pleural effusion, with the procedure typi-
cally performed posteriorly or along the lateral chest wall.
In all awake and cooperative patients, including those who
were mechanically ventilated, the procedure was per-
formed with the patient sitting upright and leaning over
a table. In those patients who were mechanically ventilated
and unable to follow instructions, or in those unable to sit
upright, the head of the bed was elevated to 45 and the
bilateral thoracenteses were performed from a lateral
position.
The patient’s skin was cleaned with chlorhexidine and
the procedures were performed in sterile fashion by two
operators simultaneously using the Safe-T-Centesis Kit
(Cardinal Health, Dublin, OH). Fluid was removed by
manual aspiration until it no longer returned. The intent for
every thoracentesis was to remove the entire volume of
fluid in the pleural cavity. We evacuated the effusion to
provide symptomatic relief and to minimize the risk of
repeated procedures. Complete removal of the pleural
effusion has been endorsed in the literature.4 The fluid
volume was measured, and samples were routinely sent for
cell count with differential, total protein, lactate dehy-
drogenase (LDH), glucose, pH, cultures, and cytology.
Light’s criteria were applied to determine whether each
effusion was transudative or exudative.2 Etiologies of the
pleural effusions were determined from clinical history,
laboratory data, volume status and radiology, including
echocardiography. Pleural fluid etiologies were categorized
according to the schema presented in Table 1. If patients
met criteria for more than one etiology they were classified
as having multiple etiologies for their pleural effusion. We
also compared characteristics of the pleural fluid drawn
from left and right sides for disparities in clinical charac-
teristics, i.e., exudative versus transudative.
Flow cytometry was performed when lymphoma was
a consideration. Effusions were considered to be secondary
to malignancy if cytology demonstrated malignant cells or
flow cytometry was positive. Cells were considered atypical
when the cytopathologist identified abnormal cells but
could not definitively characterize them as malignant based
on their appearance.
Pre- and post-procedure chest radiographs (CXR) were
performed in all patients. The CXRs were read indepen-
dently by two chest radiologists blinded to the study and
patient information. Pneumothorax, worsened edema,
worsened infiltrates and improvements in the radiographs
were noted when present.Statistical analysis
Descriptive statistics were ascertained as appropriate
and the rate and 95% confidence interval of iatrogenic
pneumothoraces subsequent to concurrent bilateral
Table 1 Definitions for pleural fluid etiology.
Congestive heart failure:
Echocardiogram within 1 month or at the time of procedure which documents:
 Decreased ejection fraction (45%) and pulmonary edema on CXR
 Diastolic dysfunction and pulmonary edema on CXR
 Moderate to severe aortic stenosis (valve area < 1 cm), aortic regurgitation, mitral stenosis or mitral regurgitation
and pulmonary edema on CXR
 Restrictive and/or constrictive pericardial disease and pulmonary edema on CXR
 Severe pulmonary hypertension
or
 Cardiac arrhythmia on EKG (atrial fibrillation) and pulmonary edema on CXR
Renal failure:
 Nephrotic range proteinuria documented in medical record
 Creatinine > 1.5 mg/dl
 Patient receiving Renal Replacement Therapy (RRT)
Liver failure:
 Documented cirrhosis with ascites
 Acute, fulminate liver failure
Hypoalbuminemia:
 Albumin  2 g/dl
Resuscitation
 Active fluid resuscitation and pulmonary edema without heart failure, renal failure or liver failure
Pneumonia/Infection:
 Infiltrate on CXR (ipsilateral side) and greater than 500 WBC cells/mL in fluid
 Infiltrate on CXR (ipsilateral side) and positive pleural fluid culture
Malignancy:
 Positive pleural fluid cytology or definitive immunohistochemistry (not atypical cells)
 Positive flow cytometry
CXR Z chest X-ray EKG Z electrocardiography WBC Z white blood cells.
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differences in fluid levels of glucose, protein, LDH, and pH
between each participant’s right and left effusions were
tested against a null value of zero. The unadjusted asso-
ciations of clinically important covariates and the occur-
rence of bilateral malignant effusions were determined,
and a multivariable logistic model including age and sex
was selected with a manual forward selection procedure
that has been described previously.5 Goodness of fit was
verified by examination of model residuals and with the
HosmereLemeshow statistic. We assessed model discrimi-
nation by estimating the area under the ROC curve using a C
statistic. All statistical tests were two-tailed with P < 0.05
indicating significance. Statistical analyses were performed
with SAS statistical software, version 9.2.
Results
Characteristics of participants and their pleural
fluid
Of the 100 patients enrolled in this study, 54 were female
and 92 were inpatients. A total of 24 patients had the
thoracentesis performed either on mechanical ventila-
tion or non-invasive ventilatory support. A descriptive
analysis of patient demographics and the contents of
their pleural fluid are presented in Table 2. Becausethere was, on average, a larger volume of effusion
aspirated from patients’ right sides, Table 2 presents the
level of clinically relevant components from the right-
sided effusion only.
Paired t-tests were performed on the levels of protein,
LDH, glucose and pH in fluid taken from the right and left
sides with no significant difference identified. There was
only one empyema and that was in a patient who had an
indwelling drainage catheter and no patient had bilateral
empyema. Of the 19 patients with cytologically positive
bilateral malignant pleural effusions, five had breast
adenocarcinoma, five had lung adenocarcinoma and five
others were adenocarcinoma from additional primary sites
(uterus, pancreas (2), gastric and unknown). The four
remaining were pulmonary large cell, lymphoma (2) and T-
cell promyelocytic leukemia. An additional five patients
had unilateral malignant effusions with cytologic atypia on
the contralateral side. All of these were adenocarcinoma
(lung (2), colon, gastric and pancreatic). Atypical cells were
present bilaterally in five additional patients.Characterizing the etiology of the bilateral pleural
effusions
Fifty-three patients had bilateral exudates, 35 had bilateral
transudates and there were twelve persons for whom one
side was a transudate and the other an exudate. The two
Table 2 Patient demographics (N Z 100).
Characteristic Mean [SD]
or n (%)
Age in years, mean [SD] 70.9 [15.9]
Female 54 (54)
Inpatient 92 (92)
Ventilatory support 25 (25)
Mechanical ventilation 17 (17)
Bilevel positive airway
pressure (BiPAP)
7 (7)
Pleural fluid results
Bilateral transudates 35 (35)
Bilateral exudates 53 (53)
Bilateral non-matching
(exudate & transudate)
12 (12)
Bilateral malignant effusions 19 (19)
Complications recorded by
radiologists within 24 h
of thoracentesis
Pneumothorax 7 (7)
Edema 12 (12)
Atelectasis 1 (1)
New Infiltrate 7 (7)
Analysis of pleural fluid extracted from right side of patients
Characteristic Median
{Range} or n (%)
Fluid volume removed 875.0 {5e2000}
Glucose (mg/dl) 131.0 {2e282}
Lactate dehydrogenase (U/L) 143.0 {35e2700}
Protein (g/dL) 2.4 {0.6e6.40}
pH 7.46 {7.16e7.63}
Granulocytes% 12.5 {1e98}
Lymphocytes% 25.0 {0e86}
Red blood cells 1460.5 {3e267,000}
Microbiology, negative n (%) 97 (97)
*Missing data: glucose right (nZ 2), granulocytes right (nZ 1),
LDH right (nZ 1), pH right (nZ 1), microbiology right (nZ 1).
Bilateral pleural effusion etiologies 287pie charts of Figs. 1 and 2 depict, respectively, the
proportional breakdown of the attributed etiologies of the
exudative and transudative effusions. We only included
patients in which both effusions were either transudative or
exudative, so the twelve patients who had one side as
a transudate and one side as an exudate are not included in
Fig. 1. In 13% of effusions no definitive etiology was de-
termined. Forty-seven percent of patients with exudates
had more than one etiology for their pleural effusion, of the
15 distinct combinations observed, six included congestive
heart failure and ten included renal failure. Of the
exudates, malignancy was the most common single
etiology, followed by congestive heart failure and a low
protein state. Eighty-three percent of patients with bilat-
eral transudates had more than one etiology for their
effusion. Of the 12 distinct combinations observed, eight
included congestive heart failure and seven included renal
failure. Of the transudates in our sample, the most common
single etiology was congestive heart failure, followed by
liver failure.Modeling the occurrence of bilateral malignant
effusion
With 19 patients exhibiting bilateral malignant effusions, it
was the most common cause of exudative effusion. We
examined the unadjusted associations between character-
istics of the effusions and occurrence of bilateral malignant
effusion. Table 3 provides the bivariate associations
between patient characteristics and the occurrence of
bilateral malignant effusion calculated from logistic
regression. As was done for Table 2, we report associations
with the fluid characteristics of bilateral malignant effusion
from the right side only. Among the demographic charac-
teristics, age alone showed a marginal association. We
observed that higher levels of protein and LDH were
significantly associated with occurrence of bilateral malig-
nant effusions. Correspondingly, lower levels of glucose and
pH demonstrated significant bivariate associations. A posi-
tive diagnosis of malignancy was precluded from use in the
models because all but one case of bilateral malignant
effusion were characterized by previous diagnoses of
malignancy. We subsequently fit a multivariable model that
consisted of age, sex, protein and glucose. Among these
four explanatory variables, only protein and glucose
exhibited marginal associations with P-values of 0.05 and
0.06, respectively. With a C statistic of 0.82 and no rejec-
tion of HosmereLemeshow goodness of fit, this multivari-
able model showed good ability to predict occurrence of
bilateral malignant effusions.
Safety of concurrent bilateral thoracentesis
Of the 200 concurrent bilateral procedures performed,
seven resulted in pneumothoraces, representing a rate (95%
CI) of 3.6% (1.7, 7.7). In our sample, the number of pneu-
mothoraces requiring chest tube placement was three,
representing 1.5% of all procedures. In all cases, an expe-
rienced operator was available to handle complications and
none of the patients developed persistent bronchopleural
fistula or died. All pneumothoraces occurred on the right
side and were characterized by removal of larger volumes
of fluid. The volume of fluid removed was more than 1.5 L in
each of our cases of pneumothorax. The four other pneu-
mothoraces not requiring chest tube placement repre-
sented “ex vacuo” spaces in which the lung did not re-
expand. The causes of ex vacuo pneumothoraces included
one patient with a perforated atrium following a pace-
maker placement, one patient with an inferior vena cava
stenosis and chronic effusions following treatment for
lymphoma, and one patient with bilateral malignant
effusions.
Discussion
Pleural effusions are a common clinical problem in medical
practice and occur in patients with heart, liver, and renal
failure as well as malignancy. Prior literature suggests that
effusions can be bilateral in anywhere from 15 to 55% of
patients.2 Prior to this study, there has been little published
information regarding the etiologies or safety of bilateral
thoracentesis.
Figure 1 Pie chart of exudative effusion etiologies. Malignancy was the most common single etiology of bilateral exudates. The
majority of patients had multiple etiologies for their effusions.
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In this study most of the bilateral effusions, whether
exudative or transudative, were attributed to multiple
etiologies; 83% of the transudates and 47% of the exudates
respectively. In the current study, 19 patients (19%) had
malignancy as a cause of bilateral effusion. In two previ-
ously described studies, malignancy was found in 35
patients (45%) among the first study’s general population,1
but no malignancy was identified in the second study.2 Only
one patient with bilateral malignant effusions in our study
had no prior history of malignancy. Of the patients with
bilateral malignant effusions, one patient had bilateral
transudative effusions, one patient had a transudate and an
exudate and all others were bilateral exudative effusions.
This is consistent with the literature reporting that the
majority of malignant effusions are exudates. Patients with
bilateral pleural effusions and a history of malignancy
should raise suspicion for malignant involvement of both
hemithoraces.
Our analysis of fluid drawn simultaneously from both
lungs showed no statistical difference between sides in
traditionally measured components used to determine
whether the fluid is exudative versus transudative. This
finding was also reported by Kalomenidis et al.2 In contrast
with that cardio-centric sample, our bilateral samples were
drawn from a more diverse medical population and may
therefore suggest greater generalizability of the observedsimilarity in makeup of fluid from both effusions. In rare
circumstances, the etiology of the pleural effusion was
different between sides. For example, unilateral pneu-
monia requiring systemic fluid resuscitation led to different
pleural fluid characteristics in which only the side with
pneumonia was exudative. In another case, one side was
chylous. In another, cholecystectomy led to a right-sided
inflammatory effusion, while the left side was a transu-
date. Finally, one patient had a unilateral malignant effu-
sion and developed bilateral effusions after resuscitation
for bacteremia; in this case, the contralateral effusion was
not malignant. Sometimes, the reason for differences
between sides was not clearly determined on clinical
grounds.
Our results support findings from other studies regarding
which tests to include in pleural fluid analysis. Routine
pleural fluid cultures may not be needed in the presence of
bilateral effusions without a clear clinical picture of
pneumonia. In our study, only four patients had pneumonia
and only one effusion was culture-positive, the latter
effusion caused by an indwelling tube.
Safety of concurrent bilateral thoracentesis
There is disagreement in the literature regarding the adverse
outcomes associated with large volume removal of pleural
fluid. The two main adverse outcomes are pneumothorax
and re-expansion pulmonary edema. Many factors likely
Figure 2 Pie chart of transudative effusion etiologies. Heart failure was the most common single etiology of the bilateral
transudates. The majority of patients had multiple etiologies for their effusions.
Bilateral pleural effusion etiologies 289contribute to these adverse outcomes including etiology of
the effusion, how long the effusion has been present and
technique of removal. A study by Josephson et al. demon-
strated that pneumothorax was more common in patients
that had greater than 1.8 L removed.6 In that study thereTable 3 Bivariate associations between patient characteristics
Mean or prevalenc
Demographics
Age in years, mean  SD 70.9 (15.9)
Female gender 0.54
Serum values
Protein 5.8 (1.0)
Lactate dehydrogenase 303.6 (136)
Analysis of pleural fluid extracted from right side of patients
Glucose 133.1 (47)
Lactate dehydrogenase 267.2 (388.2)
Protein 2.49 (1.2)
pH 7.44 (0.1)
Granulocytes% 22.9 (23.1)
Lymphocytes% 31.7 (24.9)
Red blood cells 13,775.3 (36739.7
Microbiology, negative 0.02were 735 thoracenteses performed in 471 patients suggest-
ing recurring development of pleural fluid in their population
so that repeated thoracentesis and not the volume removed
could have been the true risk factor for pneumothorax.
Several other studies have not found an association withand occurrence of bilateral malignant effusion (N Z 100).
e Coefficient P-value
0.03 0.04
0.59 0.25
0.14 0.61
0.001 0.61
0.02 <0.001
0.002 0.003
0.83 <0.001
6.85 0.02
0.03 0.02
0.003 0.80
) 0.0001 0.01
1.5 0.32
290 J.T. Puchalski et al.volume removal and pneumothorax or re-expansion pulmo-
nary edema.4,7 The most recent British Thoracic Society
guidelines acknowledge that the amount of fluid that can be
safely removed is debatable.8
Our observational sample of 100 patients suggests that
ultrasound-guided bilateral thoracentesis demonstrates
safety comparable with that of unilateral thoracentesis.
Our rate of pneumothorax was 3.6%, which is lower than the
rate reported by Gordon et al.3 for unilateral thoracentesis,
i.e., 6.0% (CI: 4.6, 7.8). They also reported that 2% of all
procedures required chest tube placement, similar to our
1.5% rate of chest tube placement. Four patients did not
require chest tube placement because their pneumothorax
was considered ex vacuo. This is in accordance with the
British Thoracic Society guidelines.8 In addition a study by
Boland et al. demonstrated improvement in patient symp-
toms with fluid removal despite occurrence of an ex vacuo
pneumothorax.9 All of our pneumothoraces occurred when
greater than 1.5 L of fluid was removed. This finding is
similar to a prior study in which the pneumothorax rate was
higher for effusions that were 1.8e2.2 L (three-fold
increase) or more than 2.2 L (six-fold increase).6 It should
be noted, however, that in our study the great majority of
patients with more than 1.5 L of pleural fluid removed did
not develop a pneumothorax. Twenty-four of our patients,
representing 48 thoracenteses, underwent their procedure
while on positive pressure ventilation without an increased
rate of adverse outcomes and only one had a pneumothorax
requiring intervention. Therefore, contrary to conventional
wisdom, we propose that thoracenteses can be performed
safely in both hemithoraces at the same time, even in
mechanically ventilated patients. Until further data is
available it may be prudent to remove less than 1.5 L
from each hemithorax when performing a bilateral
thoracentesis.
There are several plausible benefits from performing
concurrent bilateral thoracentesis. They include reduction
in the overall time spent by physician and medical staff in
positioning the patient, as well as faster relief of symp-
toms. The concurrent bilateral procedure also reduces
patient exposure to radiation as it eliminates replication
of radiographs in those cases where the physician orders
a CXR following each unilateral procedure. Given that
prior studies have demonstrated improvement in FEV1,
FVC and arterial oxygenation with removal of fluid
volumes ranging from 600 to 2700 ml, the same effects
were likely occurring in our sample.10 These changes in
lung function may lead to improved symptoms and patient
satisfaction, as well as earlier diagnosis and hospital
discharge.
There are notable limitations to this study. Because the
primary outcomes of this study were determining etiologies
and safety, patient symptoms were not quantitatively
measured before and after the procedure. The magnitude
of therapeutic benefit was therefore not directly assessed.
Future studies should document improvement in symptoms
with bilateral thoracentesis. This study was conducted in
a medical population whereas a post-surgical population
may have other etiologies for their bilateral effusions.
Another limitation is that we did not systematically capture
the clinician’s reason for requesting a bilateral thoracent-
esis although for many of the cases it was due to refractoryeffusions that were not responding to diuretic therapy or
hemodialysis, unexplained fever or for symptomatic relief.
Although in our study two operators performed the thor-
acentesis at the same time, bilateral thoracentesis could be
performed with ultrasound guidance in an immediate
sequential manner by one operator without performing
a chest radiograph between the procedures. This approach
would be practical in a community setting where an expe-
rienced clinician using ultrasound could do serial thor-
acentesis without taking excess time to reposition the
patient or to wait for separate radiographs to be performed
between procedures.Conclusions
In most patients, multiple etiologies contributed to the
information of bilateral pleural effusions. In the absence
of a unilateral pneumonia, unilateral subdiaphragmatic
surgical procedures, or obvious reasons for dissimilar
results, most bilateral pleural effusions are anticipated to
have similar fluid characteristics and etiologies. In this
observational prospective cohort study, concurrent bilat-
eral thoracentesis demonstrates a rate of iatrogenic
pneumothoraces comparable to that of unilateral thor-
acentesis. Concurrent bilateral thoracentesis can be safely
performed with the guidance of ultrasound and the manual
evacuation of fluid with at least one experienced operator
present.Author contribution
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